Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses

Joshua E. Reuss, Paul K. Lee, Reza J. Mehran, Chen Hu, Suqi Ke, Amna Jamali, Mimi Najjar, Noushin Niknafs, Jaime Wehr, Ezgi Oner, Qiong Meng, Gavin Pereira, Samira Hosseini-Nami, Mark Sausen, Marianna Zahurak, Richard J. Battafarano, Russell K. Hales, Joseph Friedberg, Boris Sepesi, Julie S. Deutsch, Tricia Cottrell, Janis Taube, Peter B. Illei, Kellie N. Smith, Drew M. Pardoll, Anne S. Tsao, Julie R. Brahmer, Valsamo Anagnostou, Patrick M. Forde

Open source

DOI: 10.1038/s41591-025-03958-3
Published: 2025-09-08
Container: Nature Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-025-03958-3,
  title = {Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses},
  author = {Joshua E. Reuss and Paul K. Lee and Reza J. Mehran and Chen Hu and Suqi Ke and Amna Jamali and Mimi Najjar and Noushin Niknafs and Jaime Wehr and Ezgi Oner and Qiong Meng and Gavin Pereira and Samira Hosseini-Nami and Mark Sausen and Marianna Zahurak and Richard J. Battafarano and Russell K. Hales and Joseph Friedberg and Boris Sepesi and Julie S. Deutsch and Tricia Cottrell and Janis Taube and Peter B. Illei and Kellie N. Smith and Drew M. Pardoll and Anne S. Tsao and Julie R. Brahmer and Valsamo Anagnostou and Patrick M. Forde},
  year = {2025},
  journal = {Nature Medicine},
  doi = {10.1038/s41591-025-03958-3},
  url = {https://doi.org/10.1038/s41591-025-03958-3}
}

RIS

TY  - JOUR
TI  - Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses
AU  - Joshua E. Reuss
AU  - Paul K. Lee
AU  - Reza J. Mehran
AU  - Chen Hu
AU  - Suqi Ke
AU  - Amna Jamali
AU  - Mimi Najjar
AU  - Noushin Niknafs
AU  - Jaime Wehr
AU  - Ezgi Oner
AU  - Qiong Meng
AU  - Gavin Pereira
AU  - Samira Hosseini-Nami
AU  - Mark Sausen
AU  - Marianna Zahurak
AU  - Richard J. Battafarano
AU  - Russell K. Hales
AU  - Joseph Friedberg
AU  - Boris Sepesi
AU  - Julie S. Deutsch
AU  - Tricia Cottrell
AU  - Janis Taube
AU  - Peter B. Illei
AU  - Kellie N. Smith
AU  - Drew M. Pardoll
AU  - Anne S. Tsao
AU  - Julie R. Brahmer
AU  - Valsamo Anagnostou
AU  - Patrick M. Forde
PY  - 2025
JO  - Nature Medicine
DO  - 10.1038/s41591-025-03958-3
UR  - https://doi.org/10.1038/s41591-025-03958-3
ER  -

APA

Reuss, J. E., Lee, P. K., Mehran, R. J., Hu, C., Ke, S., Jamali, A., Najjar, M., Niknafs, N., Wehr, J., Oner, E., Meng, Q., Pereira, G., Hosseini-Nami, S., Sausen, M., Zahurak, M., Battafarano, R. J., Hales, R. K., Friedberg, J., Sepesi, B., Deutsch, J. S., Cottrell, T., Taube, J., Illei, P. B., Smith, K. N., Pardoll, D. M., Tsao, A. S., Brahmer, J. R., Anagnostou, V., & Forde, P. M. (2025). Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses. Nature Medicine. https://doi.org/10.1038/s41591-025-03958-3

Source records

crossref · retrieved 2026-09-25T23:12:29.740Z